SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathwayL-J Yuan(Sun Yat-sen University Cancer Center), Min Zheng(Second Affiliated Hospital of Zhejiang University)Cell Death and DiseaseMay 22, 201410.1038/cddis.2014.222Cited by 90SaveCiteExport RISWatch citationsRelated PapersThe MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages|Cancer Cell International|2023|27Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV Sources|PLoS ONE|2013|22